GlassScriptPhysician profile
Meagan Mcdavid
NPI 1033562889
$1,289.44
in general payments reported to CMS, 2019-2025
12 companies · $152 in 2025
The $152 reported for 2025 was more than what 75% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $183 · 2021: $447 · 2022: $340 · 2023: $29.41 · 2024: $34.60 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $215.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $272.61 | 2019-2021 | |
| Medtronic, INC. | $263.99 | 2021-2022 | |
| Spr Therapeutics, INC | $237.40 | 2021-2022 | |
| Medtronic USA, INC. | $137.59 | 2020 | |
| Grt US Holding, INC. | $116.67 | 2022 | |
| Boston Scientific Corporation | $109.20 | 2024-2025 | General - Pain Management |
| Becton, Dickinson and Company | $38.97 | 2025 | Hemosphere |
| Haemonetics Corporation | $37.93 | 2025 | Teg6s Hemostasis System |
| Hemosonics LLC | $29.41 | 2023 | Quantra Qplus System |
| Merck Sharp & Dohme LLC | $16.14 | 2020 | |
| Stimwave Technologies Incorporated | $14.80 | 2020 | |
| Lilly USA, LLC | $14.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meagan Mcdavid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.